Tasso Secures Additional North American and European Regulatory Clearances for Tasso™ Mini Device

New regulatory clearances enable the Tasso Mini to be sold in Canada, Italy, and Spain

SEATTLE – July 15, 2025 – Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced new regulatory clearances for the Tasso™ Mini device. Tasso Mini is now licensed with Health Canada and has secured additional approvals in the European Union to expand into Italy and Spain. The new clearances expand Tasso Mini's availability beyond the current U.S. FDA Class II 510(k) clearance and European CE Marking.

Tasso Mini is the newest addition to Tasso’s virtually painless, patient-centric blood lancet portfolio. The device is optimized for a gentle sample collection experience, ideal for use with sensitive populations or for repeat sampling applications. The new clearances expand Tasso Mini’s availability to match that of Tasso’s flagship Tasso+® device, providing more options for international customers.

“Patients worldwide are seeking a blood collection experience that is tailored to their needs,” said Ben Casavant, PhD, CEO and Co-Founder of Tasso. “Tasso Mini unlocks new sampling capabilities for the most sensitive patients. These additional regulatory clearances demonstrate our commitment to creating innovative, trusted solutions that expand care options for patients everywhere.”

To learn more about Tasso Mini, please visit https://www.tassoinc.com/tasso-mini.

 

 

About Tasso

Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders. For more information, please visit www.tassoinc.com.

 

Media Contact

Dina Schneider

(206) 822-4186 x1016

media@tassoinc.com

Next
Next

SNBL and Tasso, Inc. to Establish Joint Venture in Japan